MVP and vinorelbine for malignant pleural mesothelioma.
Mordant
P
P
Loriot
Y
Y
Soria
J C
JC
Deutsch
E
E
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy*; D008937:Mitomycins / Q000627:therapeutic use; D010997:Pleural Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
D000972:Antineoplastic Agents, Phytogenic; D008937:Mitomycins; D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine